MilliporeSigma Launches New Contract Development Manufacturing Facility for Gene Therapy
MilliporeSigma today announced the opening of its second Carlsbad, California-based facility, significantly expanding its CDMO footprint.
Precigen Opens Gene and Cell Therapy Manufacturing Facility in Germantown, Maryland
Precigen commenced the build-out of the nearly 5,000 square foot manufacturing facility in 2018 to support gene therapy manufacturing. The good manufacturing practices (GMP) facility was designed with agility and control in mind, focusing on rapid manufacturing and the ability to scale production appropriately to meet early stage clinical trial needs.
New Stem Cell Gene Therapy Facility
Stem Cell Medicine Ltd. (SCM), a biotechnology company developing new therapies for neurological indications and rare diseases through gene therapy, cell therapy, exosomes, novel molecules and combinations with existing pharmaceuticals, announced today that it has received funding from the Israeli Ministry of the Economy to build a gene therapy facility.
